Education
About Us
Working with TipRanks
Follow Us
Panacea Innovation Limited Insider Profile
11 Followers
Panacea Innovation Limited, Ten Percent Owner at Atara Biotherapeutics, holds 1.35M shares in Atara Biotherapeutics (Ticker: ATRA). Most recently, Panacea Innovation Limited Bought $19,335 shares of Atara Biotherapeutics on Jul 21, 2025 for an estimated value of 186.20K.
Panacea Innovation Limited has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Panacea Innovation Limited's holdings
Insider Roles
Ten Percent Owner
Roles that Panacea Innovation Limited holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Panacea Innovation Limited
Panacea Innovation Limited's Trading History
List of latest transactions for each holding click on a transaction to see Panacea Innovation Limited's performance on stock
You May Also Like
Panacea Innovation Limited insider profile FAQ
What is the percentage of profitable transactions made by Panacea Innovation Limited?
The percentage of profitable transactions made by Panacea Innovation Limited is ―.
What is the average return per transaction made by Panacea Innovation Limited?
The average return per transaction made by Panacea Innovation Limited is ―.
What stocks does Panacea Innovation Limited hold?
Panacea Innovation Limited holds: ATRA stocks.
What was Panacea Innovation Limited’s latest transaction?
Panacea Innovation Limited latest transaction was an Informative Buy of $186.20K.
What was Panacea Innovation Limited's most profitable transaction?
Panacea Innovation Limited’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Panacea Innovation Limited's role in Atara Biotherapeutics?
Panacea Innovation Limited's role in Atara Biotherapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.